China NMPA Inspection - National Medical Products Administration - January 22, 2020

The Jiangsu Provincial Drug Administration's Cosmetics Supervision Division convened a meeting on January 22, 2020, to strategize its 2020 provincial supervision and inspection plan for cosmetics manufacturers. This initiative operates within the established "Jiangsu Province Cosmetics Manufacturer Supervision and Inspection Procedures" and anticipates upcoming "Cosmetics Supervision and Management Regulations," emphasizing a comprehensive, risk-based regulatory approach. The plan's core objective is risk prevention through various inspection types, including unannounced, special, and follow-up audits. Key areas of concern for inspections include ensuring adherence to quality and safety standards, addressing manufacturing deficiencies, maintaining manufacturer credit systems, and managing problematic products. Specific required actions for the regulatory body and its inspection branches include: coordinating provincial personnel for unannounced inspections under a team leader responsibility system; conducting daily, risk-assessed supervision by local branches with quarterly reporting; mandating prompt rectification for identified issues, ensuring closed-loop management, and escalating illegal activities; bolstering risk assessment through dedicated meetings and data analysis; and upholding public transparency by disclosing inspection information on the Provincial Bureau's website and the "Internet + Supervision" platform. This structured plan aims to bolster regulatory effectiveness and enhance consumer product safety.